AI assistant
Moderna, Inc. — Director's Dealing 2026
Mar 3, 2026
30610_dirs_2026-03-03_bb2f8b34-e574-4f7e-b8f4-ee5ed10c3686.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2026-02-27
Reporting Person: Klinger Shannon Thyme (Chief Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-27 | Common Stock | M | 233 | — | Acquired | 54760 | Direct |
| 2026-02-27 | Common Stock | F | 113 | $51.71 | Disposed | 54647 | Direct |
| 2026-02-27 | Common Stock | M | 329 | — | Acquired | 54976 | Direct |
| 2026-02-27 | Common Stock | F | 160 | $51.71 | Disposed | 54816 | Direct |
| 2026-02-27 | Common Stock | M | 774 | — | Acquired | 55590 | Direct |
| 2026-02-27 | Common Stock | F | 375 | $51.71 | Disposed | 55215 | Direct |
| 2026-02-27 | Common Stock | M | 8663 | — | Acquired | 63878 | Direct |
| 2026-02-27 | Common Stock | F | 4189 | $51.71 | Disposed | 59689 | Direct |
| 2026-03-02 | Common Stock | M | 13885 | $30.96 | Acquired | 73574 | Direct |
| 2026-03-02 | Common Stock | S | 13885 | $52.29 | Disposed | 59689 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | Restricted Stock Units | $ | M | 233 | Disposed | Common Stock (233) | Direct | |
| 2026-02-27 | Restricted Stock Units | $ | M | 329 | Disposed | Common Stock (329) | Direct | |
| 2026-02-27 | Restricted Stock Units | $ | M | 774 | Disposed | Common Stock (774) | Direct | |
| 2026-02-27 | Restricted Stock Units | $ | M | 8663 | Disposed | Common Stock (8663) | Direct | |
| 2026-03-01 | Stock Option (Right to Buy) | $53.57 | A | 29275 | Acquired | 2036-03-01 | Common Stock (29275) | Direct |
| 2026-03-01 | Restricted Stock Units | $ | A | 38553 | Acquired | Common Stock (38553) | Direct | |
| 2026-03-02 | Stock Option (Right to Buy) | $30.96 | M | 13885 | Disposed | 2035-03-01 | Common Stock (13885) | Direct |
Footnotes
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025.
F4: 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F5: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F6: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F7: 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F8: 25% of this option will vest and become exercisable on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F9: 25% of the shares subject to this restricted stock unit award will vest on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F10: 25% of this option vested and became exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.